Unknown

Dataset Information

0

The chemical biology of IL-12 production via the non-canonical NFkB pathway.


ABSTRACT: Interleukin-12 (IL-12) has emerged as an attractive cytokine for cancer therapy because it has direct anti-cancer effects and additionally plays a critical role in enhancing checkpoint inhibitors. Given these multiple modes of actions, identifying means to pharmacologically induce IL-12 production in the tumor microenvironment has become important. In this review, we highlight therapeutics that promote IL-12 induction in tumor-associated myeloid cells through the non-canonical NFkB pathway. We discuss existing clinical trials and briefly examine the additional pathway targets that warrant further exploration for drug discovery.

SUBMITTER: Koch PD 

PROVIDER: S-EPMC8341911 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4555999 | biostudies-literature
2015-07-07 | E-GEOD-61677 | biostudies-arrayexpress
2015-07-07 | GSE61677 | GEO
| MSV000082955 | MassIVE
| S-EPMC6814021 | biostudies-literature
| S-EPMC5680241 | biostudies-literature
| S-EPMC7403597 | biostudies-literature
2022-12-31 | GSE196099 | GEO
2012-10-01 | E-GEOD-34990 | biostudies-arrayexpress
| S-EPMC4806302 | biostudies-literature